The TRUS-guided prostate biopsy has been a standard procedure for prostate cancer detection for more than thirty years and it is recommended in male patients with abnormal PSA, or an abnormality felt on a digital rectal examination [19]. The gene discussed is KLK3; the disease is Familial prostate cancer.